Atlas Trials

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY)

Clinical trial NCT02742480 · UNKNOWN

Trial details

NCT number
NCT02742480
Sponsor
Hospital Mutua de Terrassa
Status
UNKNOWN
Study type
OBSERVATIONAL
Cardioembolic Stroke
Start date
2016-06-28
Primary completion
2019-06-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.